Nat. Biotechnol. 21, 865–870 (2003)
In Box 3 of the article on p. 868, it was stated that the Dutch company Pharming NV went bankrupt in 2001. In that year the company did go into receivership and its subsidary (Pharming intellectual property BV) was declared bankrupt. We fully accept, however, that Pharming itself did not go bankrupt. Pharming continues to trade successfully and currently has a number of products in both preclinical and clinical trials. NBT regrets the error.
Additional information
The online version of the original article can be found at 10.1038/nbt0803-865
Rights and permissions
About this article
Cite this article
Walsh, G. Erratum: Biopharmaceutical benchmarks—2003. Nat Biotechnol 21, 1396 (2003). https://doi.org/10.1038/nbt1103-1396a
Issue date:
DOI: https://doi.org/10.1038/nbt1103-1396a
This article is cited by
-
The humanization of N-glycosylation pathways in yeast
Nature Reviews Microbiology (2005)
